Pursuant to Regulation 44 (3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Godavari Drugs has informed about the Voting results of 29th Annual General Meeting held on September 12, 2017 along with the Consolidated Report of Scrutinizer VSS & Associates, Company Secretaries.
The above information is a part of company’s filings submitted to BSE.